Esquire Financial Holdings, Inc.·4

Feb 2, 12:22 PM ET

Lacapria Michael 4

4 · Esquire Financial Holdings, Inc. · Filed Feb 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Esquire Financial (ESQ) CFO Michael Lacapria Receives Award

What Happened Michael Lacapria, Chief Financial Officer of Esquire Financial Holdings, was granted 1,164 shares of restricted stock on January 29, 2026. The shares were awarded at a $0.00 per-share price (compensation award), so the reported acquisition value is $0. This is a grant (code A), not an open-market purchase or sale.

Key Details

  • Transaction date: January 29, 2026; Grant type: restricted stock award (A).
  • Shares granted: 1,164; Price per share: $0.00; Reported value: $0.
  • Vesting: Footnote F1 states these restricted shares vest in three equal annual installments commencing January 29, 2029.
  • Filing: Report filed February 2, 2026 — within the SEC two-business-day window for a Jan 29 transaction (timely).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Other footnotes in the filing indicate Lacapria holds additional restricted stock and options with various vesting schedules (F2–F6) and that some options are fully vested (F7) or vest over time (F8).

Context This was a compensation grant of restricted stock, which vests over time and is typically part of executive pay packages; such awards are common and do not by themselves indicate a buy or sell signal. For full ownership totals and the complete vesting/option details, consult the complete Form 4 filing (Accession 0001437749-26-002641).

Insider Transaction Report

Form 4
Period: 2026-01-29
Lacapria Michael
SVP & Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1][F2][F3][F4][F5][F6]
    2026-01-29+1,16417,606 total
Holdings
  • Common Stock

    (indirect: By IRA)
    3,250
  • Stock Options

    [F7]
    Exercise: $24.90From: 2019-12-10Exp: 2028-12-10Common Stock (1,500 underlying)
    1,500
  • Stock Options

    [F7]
    Exercise: $20.85From: 2021-12-16Exp: 2030-12-16Common Stock (2,500 underlying)
    2,500
  • Stock Options

    [F7]
    Exercise: $31.04From: 2022-12-09Exp: 2031-12-09Common Stock (2,500 underlying)
    2,500
  • Stock Options

    [F7]
    Exercise: $42.30From: 2023-12-19Exp: 2032-12-19Common Stock (2,500 underlying)
    2,500
  • Stock Options

    [F8]
    Exercise: $48.32From: 2024-12-15Exp: 2033-12-15Common Stock (2,500 underlying)
    2,500
Footnotes (8)
  • [F1]Shares of restricted stock vest in three equal annual installments commencing on January 29, 2029.
  • [F2]Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
  • [F3]Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
  • [F4]Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
  • [F5]Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.
  • [F6]Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.
  • [F7]Stock options are fully vested.
  • [F8]Stock options vest in three equal annual installments commencing on December 15, 2024.
Signature
/s/ Eric S. Bader, pursuant to power of attorney|2026-02-02

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4